FDA: Bioidenticals are “Public Health Concern;” Ban Likely
FDA: Bioidenticals are “Public Health Concern;” Ban Likely The agency has latched onto this false conclusion from a report it commissioned, and it is another direct threat to estriol and compounded bioidentical hormones’ future. ACT NOW TO PROTECT COMPOUNDED...
SAVE HRT
TAKE ACTION NOW! PROTECT ACCESS TO COMPOUNDED MEDICATION Please see the link below for the outline of the FDA's most recent attempt to take away and/or limit access to hormones and other critical compound ingredients and make it next to impossible to provide alternate...
Help us preserve your access to compounded medications
Compounding pharmacists from across America will be on Capitol Hill in Washington, D.C. next Tuesday, May 21 to ask Congress to act to preserve patient access to compounded medications. You can help tee-up our conversations with members of Congress by sending a message to your members of Congress NOW.
Protect Your Bio-Identical Hormones Before—Not After!—They’re Taken Away
The “National Academies of Sciences, Engineering and Medicine Health and Medicine Division” has announced1 an investigation titled Clinical Utility of Treating Patients with Compounded “Bioidentical Hormone Replacement Therapy”. The fact that this written title describing the investigation has quotation marks only around “Bioidentical Hormone Replacement Therapy” gives us a very large clue that from the start this investigation will be biased, as it can’t bring itself to fully recognize the name that has been used by physicians and the millions of individuals using this treatment since the 1980s.
Take Action to Protect Patient Access to Compounded Medications
PCCA members will be in D.C., April 9-10, for the 7th Annual ACT Legislative Conference, calling on lawmakers to support patient access to compounded medications. If you can’t join us at ACT, we need your help in contacting your Representatives now on these 2 opportunities to help patients. Please review the following information and contact your Congressional Representatives’ offices now.